Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Donald C Porter

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Biochemistry|July 14, 2004
A trojan horse approach for silencing thymidylate synthaseDeborah K West, Donald C Porter, Ruth L Saxl, et al.
The Journal of Biological Chemistry|January 1, 2004
Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cellsRichard M Harwell, Benjamin B Mull, Donald C Porter, et al.
Cells|October 9, 2019
Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based AssayJing Li, Hao Ji, Donald C Porter, et al.
Journal of Medicinal Chemistry|February 3, 2022
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched PharmacokineticsLi Zhang, Chen Cheng, Jing Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2017
CDK8/19 Mediator kinases potentiate induction of transcription by NFκBMengqian Chen, Jiaxin Liang, Hao Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activitiesDonald C Porter, Elena Farmaki, Serena Altilia, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Biochemistry|July 14, 2004
A trojan horse approach for silencing thymidylate synthaseDeborah K West, Donald C Porter, Ruth L Saxl, et al.
The Journal of Biological Chemistry|January 1, 2004
Activation of cyclin-dependent kinase 2 by full length and low molecular weight forms of cyclin E in breast cancer cellsRichard M Harwell, Benjamin B Mull, Donald C Porter, et al.
Cells|October 9, 2019
Characterizing CDK8/19 Inhibitors through a NFκB-Dependent Cell-Based AssayJing Li, Hao Ji, Donald C Porter, et al.
Journal of Medicinal Chemistry|February 3, 2022
A Selective and Orally Bioavailable Quinoline-6-Carbonitrile-Based Inhibitor of CDK8/19 Mediator Kinase with Tumor-Enriched PharmacokineticsLi Zhang, Chen Cheng, Jing Li, et al.
Proceedings of the National Academy of Sciences of the United States of America|September 1, 2017
CDK8/19 Mediator kinases potentiate induction of transcription by NFκBMengqian Chen, Jiaxin Liang, Hao Ji, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 8, 2012
Cyclin-dependent kinase 8 mediates chemotherapy-induced tumor-promoting paracrine activitiesDonald C Porter, Elena Farmaki, Serena Altilia, et al.
The Journal of Clinical Investigation|March 28, 2024
Mediator kinase inhibition reverses castration resistance of advanced prostate cancerJing Li, Thomas A Hilimire, Yueying Liu, et al.
Pageof 1